VGA039 is a once monthly, subcutaneously self-administered investigational therapy for the treatment of bleeding disorders, initially being evaluated for von Willebrand disease (VWD)Pivotal Phase 3 ...

Moderna to host an investor event via webcast on Monday, June 1 at 6:15 PM CDT CAMBRIDGE, MA / ACCESS Newswire / April 21, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on ...

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2026, after the close of the U ...

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, ...

Peer-reviewed evidence supports the use of Virtual Control Groups in nonclinical toxicology studiesWILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: ...

T’s transition to a late-stage, partnership-driven company as co-founder David Cotnoir-White becomes President & CSOMONTREAL & HIGHLAND PARK, N.J.--(BUSINESS WIRE)--Modulari-T Biosciences, a ...

Global contract research organization (CRO) transforms its regulatory affairs and unlocks efficiency gains and greater compliance confidence.NEW YORK & SINGAPORE--(BUSINESS WIRE)--In a move to address ...

PHIL Inc. today announced a significant expansion of its cash dispense capabilities, a major strategic investment that positions the company to continue serving the rapidly growing direct-to-patient ...

Partnership enables timely access to botensilimab plus balstilimab through France’s government-reimbursed Autorisation d’Accès Compassionnel (AAC) pathway and paid named-patient programs (NPP) in ...

As interest in the clinical relevance of redox metabolism grows, the need for reliable measurement tools is becoming increasingly critical. NADMED’s Scientific Advisory Board brings together globally ...

Richmond Pharmacology is pleased to announce the appointment of John Hotti as Chief Technology Officer (CTO), strengthening ...

COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's fourth authorized productmCOMBRIAX will be made available in the European Union, ...